Fig. 3From: One year of procarbazine lomustine and vincristine is poorly tolerated in low grade glioma: a real world experience in a national neuro-oncology centrePercentage of patients who received full dose (green), dose reduction (yellow) and dose omission or delay (red) for each agent for each cycle of PCV. a: overall group (n = 41), b: < 40 years old (n = 20), c ≥40 years old (n = 21)Back to article page